BPH Global Ltd
BP8
Company Profile
Business description
BPH Global Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.
Contact
96 Elizabeth Street
Block Arcade, Office 324, Level 3
MelbourneVIC3000
AUST: +61 390882049
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
31
Stocks News & Analysis
stocks
Strong finish to the year for overvalued ASX share
A great fiscal 2025 but investors are ahead of themselves.
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,080.70 | 39.80 | -0.44% |
| CAC 40 | 7,759.44 | 24.60 | 0.32% |
| DAX 40 | 23,681.27 | 125.86 | -0.53% |
| Dow JONES (US) | 45,553.31 | 38.36 | 0.08% |
| FTSE 100 | 9,239.85 | 18.41 | 0.20% |
| HKSE | 25,938.13 | 304.22 | 1.19% |
| NASDAQ | 21,818.71 | 20.01 | 0.09% |
| Nikkei 225 | 43,459.29 | 184.52 | -0.42% |
| NZX 50 Index | 13,253.73 | 27.41 | -0.21% |
| S&P 500 | 6,500.58 | 5.43 | 0.08% |
| S&P/ASX 200 | 8,803.50 | 37.40 | -0.42% |
| SSE Composite Index | 3,807.29 | 19.55 | -0.51% |